跳至主要内容
临床试验/NCT01791400
NCT01791400已完成2 期

Study of Effects of Metoclopramide Versus Sumatriptan on Migraine Headache

Isfahan University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 124 人开始时间: 2009年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
124
试验地点
1
主要终点
pain

研究概览

简要总结

The purpose of this study is to determine which drug makes lower migraine headache

详细描述

There are different options to manage benign headache in emergency department.The investigators compared Intravenous metoclopramide with Subcutaneous sumatriptan to relieve pain in emergency department.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
20 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 20-60 years old and presented with acute headache similar to previous episodes,
  • with or without phonophobia,
  • photophobia,
  • vomiting or nausea.

排除标准

  • fever or neck stiffness,
  • altered mental state,
  • pregnancy,
  • recent trauma or seizure (within 24 hours),
  • focal neurological abnormality on physical examination,
  • allergy to metoclopramide,
  • hypertension,
  • cardiovascular diseases.
  • Also if the patients had taken a triptan or ergot during the last 24 hours were excluded from the study.

研究组 & 干预措施

Metoclopramide

Other

Patients who underwent 20 mg Metoclopramide intravenous one time

干预措施: metoclopramide, injection,20mg, one time (Drug)

sumatriptan

Other

Patients who underwent 6 mg sumatriptan subcutaneous one time

干预措施: Sumatriptan, injection, 6 mg, one time (Drug)

结局指标

主要结局

pain

时间窗: at one hour after prescription

determining pain in Metoclopramide versus sumatriptan groups

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hamidreza Shemshaki

Research Assistant

Isfahan University of Medical Sciences

研究点 (1)

Loading locations...

相似试验